TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
INO

Inovio Pharmaceuticals Inc

Healthcare · Biotechnology

1.20$ +5.2% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Inovio Pharmaceuticals Inc (INO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 92.6% of the shares are freely tradable; institutional investors hold 47.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 47.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 92.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 20.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 103Mio.

Largest Shareholders

Institutions

Institutions INO
Name Stake (%) Shares Change (%) Date
FMR Inc 9.03 9,339,614 -5.1 03/31/2026
HHG PLC 3.20 3,308,406 +0.0 03/31/2026
Vanguard Capital Management, LLC 2.81 2,901,208 +0.0 03/31/2026
Boxer Capital Management, LLC 2.29 2,370,122 -2.1 03/31/2026
ADAR1 Capital Management LLC 1.42 1,470,108 -1.0 03/31/2026
D. E. Shaw & Co LP 1.31 1,351,656 -38.9 06/30/2026
Two Sigma Investments LLC 1.20 1,239,778 +217.6 06/30/2026

Funds

Funds INO
Name Stake (%) Shares Change (%) Date
Fidelity Small Cap Growth 5.45 5,632,660 +0.0 06/30/2026
Fidelity Small Cap Growth K6 2.73 2,822,120 +0.0 06/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.51 2,600,092 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?